litlas
Log inCreate account

Robert J. Fox

Active 1979–2025

Also published as
Robert J Fox
111
Papers
19,639
Citations
64
h-index
105
i10-index

Citations

Citations per year for Robert J. Fox1973: 2 citations1981: 2 citations1983: 2 citations1987: 1 citations1990: 2 citations1991: 1 citations1992: 9 citations1993: 10 citations1994: 15 citations1995: 17 citations1996: 11 citations1997: 19 citations1998: 21 citations1999: 16 citations2000: 21 citations2001: 24 citations2002: 20 citations2003: 24 citations2004: 17 citations2005: 15 citations2006: 28 citations2007: 41 citations2008: 74 citations2009: 109 citations2010: 131 citations2011: 110 citations2012: 103 citations2013: 128 citations2014: 149 citations2015: 216 citations2016: 158 citations2017: 205 citations2018: 210 citations2019: 792 citations2020: 861 citations2021: 911 citations2022: 852 citations2023: 482 citations2024: 803 citations2025: 397 citations2026: 6 citations1974–1980: no citations, so these years are not shown1982: no citations, so this year is not shown1984–1986: no citations, so these years are not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,143 citing papers, 22.4% of this breakdownGermany: 818 citing papers, 8.6% of this breakdownItaly: 736 citing papers, 7.7% of this breakdownUnited Kingdom: 728 citing papers, 7.6% of this breakdownCanada: 514 citing papers, 5.4% of this breakdownSwitzerland: 369 citing papers, 3.9% of this breakdownFrance: 339 citing papers, 3.6% of this breakdownNetherlands: 339 citing papers, 3.5% of this breakdownSpain: 330 citing papers, 3.5% of this breakdownAustralia: 329 citing papers, 3.4% of this breakdownChina: 294 citing papers, 3.1% of this breakdownAustria: 204 citing papers, 2.1% of this breakdown
0%22.4%Other 25.2%

Institutions

Fields

  • Medicine66.5%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Neuroscience12.1%
  • Immunology and Microbiology5.7%
  • Health Professions1.1%
  • Psychology0.4%
  • Other1.9%

Topics

  • Multiple Sclerosis Research Studies19.3%
  • Peripheral Neuropathies and Disorders5.3%
  • Neuroinflammation and Neurodegeneration Mechanisms4.7%
  • Neurogenesis and neuroplasticity mechanisms2.8%
  • Polyomavirus and related diseases2.8%
  • Immunotherapy and Immune Responses2.1%
  • Other63%

Coauthors

All papers

Open in search
  1. Defining the clinical course of multiple sclerosis

    Authors: Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen, Gary Cutter, Per Soelberg Sørensen, Alan J. Thompson, Jerry S. Wolinsky, Laura J. Balcer, Brenda Banwell, Frederik Barkhof, Bruce F. Bebo, Peter A. Calabresi, Michel Clanet, Giancarlo Comi, Robert J. Fox, Mark S. Freedman, Andrew Goodman, Matilde Inglese, Ludwig Kappos, Bernd C. Kieseier, John A. Lincoln, Catherine Lubetzki, Aaron E. Miller, Xavier Montalbán, Paul O’Connor, John Petkau, Carlo Pozzilli, Richard A. Rudick, Maria Pia Sormani, Olaf Stüve, Emmanuelle Waubant, Chris H. Polman - Neurology 2014 cited by 3,133

  2. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    Authors: Ludwig Kappos, Amit Bar‐Or, Bruce Cree, Robert J. Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L. Arnold, Sophie Arnould, Tatiana Scherz, Christian Wolf, Erik Wallström, Frank Dahlke, Anat Achiron, Lutz Achtnichts, Kadriye Ağan, Gülşen Akman‐Demir, Alison Allen, Jack P. Antel, Alfredo Rodríguez Antigüedad, Michelle Apperson, Angela Applebee, Guillermo Izquierdo Ayuso, Masayuki Baba, Ovidiu Băjenaru, Rodica Balasa, Belgin Petek Balcı, Michael Barnett, Ann Bass, V. Becker, Mihaela Bejinariu, Florian Then Bergh, Arnfin Bergmann, Evanthia Bernitsas, Achim Berthele, Virender Bhan, Felix Bischof, Randall J. Bjork, Gregg Blevins, Matthias Boehringer, Thomas Boerner, Robert Bonek, James D. Bowen, Allen C. Bowling, Alexey Boyко, Cavit Boz, Vera Bracknies, Stefan Braune, Vincenzo Brescia Morra, Bruno Brochet, Waldemar Brola, Paul Brownstone, M Brozman, Donald Brunet, Ioan Buraga, Margaret Burnett, Mathias Buttmann, Helmut Butzkueven, Jonathan Cahill, Jonathan Calkwood, William Camu, Mark Cascione, G. Castelnovo, Diego Centonze, João Cerqueira, Andrew Chan, Andrea Cimprichová, Stanley Cohan, Giancarlo Comi, Jill Ker Conway, Joanna A. Cooper, John R. Corboy, Jorge Correale, Brian Costell, David A. Cottrell, Patricia K. Coyle, Matthew Craner, Liying Cui, Luı́s Cunha, Anna Członkowska, Ana Silva, Joao de, de Sèze, Marc Debouverie, Jan Debruyne, D. Decoo, G. Defer, Tobias Derfuß, Norma Deri, Bhupesh Dihenia, Péter Diószeghy, Vladimír Donáth, Bénédicte Dubois, Martin Duddy, Pierre Duquette, Gilles Edan, Hüsnü Efendi, Stanton B. Elias, Peter Emrich, Bonaventura Casanova Estruch and 228 more - The Lancet 2018 cited by 925

  3. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

    Authors: Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold, Timothy R. Vollmer, Jack P. Antel, Robert J. Fox, Amit Bar‐Or, Michael Panzara, Neena Sarkar, Sunil Agarwal, Annette Langer‐Gould, Craig H. Smith - New England Journal of Medicine 2008 cited by 2,399

  4. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

    Authors: Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch, Amit Bar‐Or, Robert J. Fox, André Palma da Cunha Matta, Timothy J. Turner, Erik Wallström, Xinyan Zhang, Miroslav Mareš, Ф. А. Хабиров, Anthony Traboulsee, François Grand’Maison, François Jacques, Anthony Traboulsee, Michaela Týblová, Eva Meluzínová, Radek Ampapa, Martin Vališ, Pavel Hradilke, Miroslav Mareš, Pavel Štourač, Katrin Gross‐Paju, David Laplaud, Guillaume Mathey, Bernard M.J. Uitdehaag, Evgeny Evdoshenkoo, Е. В. Попова, Maria Zakharova, N. А. Totolyan, И. В. Литвиненко, Ф. А. Хабиров, С А Сиверцева, Viera Hančinová, Ema Kantorová, María Luisa Martínez Ginés, Xavier Montalbán, Sara Eichau Maduano, José Meca-Lallana, Lluís Ramió‐Torrentà, Tetyanna Nehrych, V.M. Pashkovskyy, Sergii Moskovko, O. I. Kalbus, Marta Khavunka, Volodymyr Pryshchepa, Alla Goloborodko, Daniel Wynn, William Honeycutt, Sibyl Wray, Brian Steingo, Christopher LaGanke, DeRen Huang, John M. Hemphill, Lawrence Goldstick, Derrick Robertson - The Lancet Neurology 2021 cited by 192

  5. Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

    Authors: Robert J. Fox, David H. Miller, J. Theodore Phillips, Michael Hutchinson, Eva Havrdová, Mariko Kita, Minhua Yang, Kartik Raghupathi, Mark Novas, Marianne T. Sweetser, Vissia Viglietta, Katherine Dawson - New England Journal of Medicine 2012 cited by 1,332

  6. Secondary Progressive Multiple Sclerosis

    Authors: Bruce Cree, Douglas L. Arnold, Jeremy Chataway, Tanuja Chitnis, Robert J. Fox, Angela Pozo Ramajo, Niamh Murphy, Hans Lassmann - Neurology 2021 cited by 252

  7. Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial

    Authors: John R. Corboy, Robert J. Fox, Ilya Kister, Gary Cutter, Charity J. Morgan, Rebecca Seale, Eric Engebretson, Tarah Gustafson, Aaron E. Miller, Dennis Bourdette, Vijayshree Yadav, Andrew Goodman, Michael K. Racke, Robert J. Fallis, Carlo Tornatore, Myla Goldman, Meena Kannan, Subramaniam Sriram, Joseph R. Berger, Anne H. Cross, Kottil Rammohan, Zongqi Xia, Thomas Leist, Sharon Lynch, Eric C. Klawiter, Lilyana Amezcua, James D. Bowen - The Lancet Neurology 2023 cited by 136

  8. Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study

    Authors: Ludwig Kappos, Robert J. Fox, Michel Burcklen, Mark S. Freedman, Eva Havrdová, Bryan T. Hennessy, Reinhard Hohlfeld, Fred Lublin, Xavier Montalbán, Carlo Pozzilli, Tatiana Scherz, Daniele D’Ambrosio, Philippe Linscheid, Andrea Vaclavkova, Magdalena Pirozek-Lawniczek, Hilke Kracker, Till Sprenger - JAMA Neurology 2021 cited by 218

  9. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

    Authors: Ranjan Dutta, Jennifer McDonough, Xinghua Yin, John W. Peterson, Ansi Chang, Thalia Torres, Tatyana I. Gudz, Wendy B. Macklin, David A. Lewis, Robert J. Fox, Richard A. Rudick, Károly Mirnics, Bruce D. Trapp - Annals of Neurology 2006 cited by 832

  10. Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

    Authors: Robert J. Fox, Christopher S. Coffey, Robin Conwit, Merit Cudkowicz, Trevis Gleason, Andrew Goodman, Eric C. Klawiter, Kazuko Matsuda, Michelle McGovern, Robert T. Naismith, Akshata Ashokkumar, Janel Barnes, Dixie Ecklund, Elizabeth Klingner, Maxine Koepp, Jeffrey D. Long, Sneha Natarajan, Brenda Thornell, Jon Yankey, Robert Bermel, Josef P. Debbins, Xuemei Huang, Patricia Jagodnik, Mark J. Lowe, Kunio Nakamura, Sridar Narayanan, Ken E. Sakaie, Bhaskar Thoomukuntla, Xiaopeng Zhou, Stephen Krieger, Enrique Álvarez, Michelle Apperson, Khurram Bashir, Bruce A. Cohen, Patricia K. Coyle, Silvia Delgado, L. Dana DeWitt, Angela Flores, Barbara S. Giesser, Myla Goldman, Burk Jubelt, Neil Lava, Sharon Lynch, Harold L. Moses, Daniel Ontaneda, Jai Perumal, Michael K. Racke, Pavle Repovic, Claire Riley, Christopher Severson, Shlomo Shinnar, Valerie Suski, Bianca Weinstock-Guttman, Vijayshree Yadav, Aram Zabeti - New England Journal of Medicine 2018 cited by 285

  11. Serum neurofilament light as a biomarker in progressive multiple sclerosis

    Authors: Raju Kapoor, Kathryn E. Smith, Mark Allegretta, Douglas L. Arnold, William M. Carroll, Manuel Comabella, Roberto Furlan, Christopher Harp, Jens Kühle, David Leppert, Tatiana Plavina, Finn Sellebjerg, Caroline Sincock, Charlotte E. Teunissen, Ilir Topalli, Florian von Raison, Elizabeth Walker, Robert J. Fox - Neurology 2020 cited by 153

  12. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

    Authors: Steve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, Nick Rijke, Jan A. Hillert, Clare Walton, Gilles Edan, Yves Moreau, Tim Spelman, Lotte Geys, Tina Parciak, Clement Gautrais, Nikola Lazovski, Ashkan Pirmani, Amin Ardeshirdavanai, Lars Forsberg, Anna Glaser, Robert McBurney, Hollie Schmidt, Arnfin B. Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Robert J. Fox, Anneke van der Walt, Helmut Butzkueven, Raed Alroughani, Serkan Ozakbas, Juan I. Rojas, Ingrid van der Mei, Nupur Nag, Rumen Ivanov, Guilherme Sciascia do Olival, Alice Estavo Dias, Melinda Magyari, Doralina Brum, Maria Fernanda Mendes, Ricardo N. Alonso, Richard S. Nicholas, Johana Bauer, Aníbal Sebastián Chertcoff, Anna Zabalza, Georgina Arrambide, Alexander Fidao, Giancarlo Comi, Liesbet Peeters - Neurology 2021 cited by 238

  13. Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results

    Authors: Ralf Gold, Douglas L. Arnold, Amit Bar‐Or, Robert J. Fox, Ludwig Kappos, Oksana Mokliatchouk, Xiaotong Jiang, Jennifer Lyons, Shivani Kapadia, Catherine Miller - Multiple Sclerosis Journal 2021 cited by 75

  14. Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis

    Authors: Patrick Vermersch, Luís Brieva, Robert J. Fox, Friedemann Paul, Lluís Ramió‐Torrentà, Matthias Schwab, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Maciej Maciejowski, on behalf of the AB07002 Study Group, Nassima Hecham, Norma Deri, Jasminka Djelilović-Vranić, Ivan Milanov, Penko Shotekov, Gregg Blevins, J Girard, Yves Lapierre, William Camu, Giovanni Castelnovo, Pierre Clavelou, P. Hautecoeur, Martin Marziniak, Christoph Mayer, Patrick Oschmann, Gerd Reifschneider, I. Schoell, Björn Tackenberg, Florian Then Bergh, Ν. Fakas, Nikolaos Grigoriadis, D. Kalochristianakis, Dimos D. Mitsikostas, Anastasios Orologas, Antonios Tavernarakis, Thomas Thomaidis, Krisztina Kovács, K Mátyás, Pálma Piros, Mária Sátori, K.J.S. Anand, Alexander L. Shifrin, Krzysztof Banaszkiewicz, Robert Bonek, M. Chahwan, M. Czernichowska - Kotiuszko, Lidia Darda-Ledzion, J. D. Wojcik, M Dziki, Ewa Krzystanek, Marianna Kulka, Paweł Lisewski, Marcin Ratajczak, Andrzej Szczudlik, Jarosław Szczygieł, Małgorzata Pańczyk-Tomaszewska, Jacek Wójcik, Daniel Zielonka, M. Chiru, Swaroopa Deme, S Mănescu, S.A. Nica, Christian Popescu, Szabolcs Szatmári, A. L. Fedyanin, N A Malkova, D.V. Popov, Л. И. Волкова, Vorob'eva Ov, M Brozman, Andrea Cimprichová, P. Cuchran, Ladislav Gurcik, Georgi Krastev, I. Lisá, M. Nyeky, J. Poljaková, Peter Turčáni, Adaani Frost, Josef G. Heckmann, Eduardo Agüera, Francisco Coret, Antonio Escartín, Victoria Fernández, JR. Ara Callizo, Greg S. Martin, José Rodríguez, M. Martinez Gines, Daniel Muñoz, Javier Olascoaga, José M. Prieto, Cristina Ramo‐Tello, Samir Belal, S. Ben Ammou, Mahbouba Frih-Ayed, Riadh Gouider, Chokri Mhiri, Ridha Mrissa, Alla Cherkez and 21 more - Neurology Neuroimmunology & Neuroinflammation 2022 cited by 67

  15. Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges

    Authors: Jeremy Chataway, Thomas Williams, Vivien Li, Ruth Ann Marrie, Daniel Ontaneda, Robert J. Fox - The Lancet Neurology 2024 cited by 63

  16. Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function

    Authors: Daniel Ontaneda, Alan J. Thompson, Robert J. Fox, Jeffrey A. Cohen - The Lancet 2016 cited by 295

  17. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies

    Authors: Sreeja Gopal, Alvydas Mikulskis, Ralf Gold, Robert J. Fox, Katherine Dawson, Lakshmi Amaravadi - Multiple Sclerosis Journal 2017 cited by 101

  18. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients

    Authors: Ranjan Dutta, Ansi Chang, Mary Kathryn Doud, Grahame J. Kidd, Michael V. Ribaudo, Elizabeth A. Young, Robert J. Fox, Susan M. Staugaitis, Bruce D. Trapp - Annals of Neurology 2010 cited by 320

  19. Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations

    Authors: Natalia Moll, Anna Rietsch, Smitha Thomas, Amy Ransohoff, Jar Chi Lee, Robert J. Fox, Ansi Chang, Richard M. Ransohoff, Elizabeth Fisher - Annals of Neurology 2011 cited by 295

  20. Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis

    Authors: Robert J. Fox, Bruce Cree, J. de Sèze, Ralf Gold, Hans‐Peter Hartung, Douglas Jeffery, Ludwig Kappos, Xavier Montalbán, Bianca Weinstock‐Guttman, Carol M. Singh, Arman Altincatal, Nicholas Belviso, Robin L. Avila, Pei‐Ran Ho, Ray Su, Robert B. Engle, Dipen Sangurdekar, Carl de Moor, Elizabeth Fisher, Bernd C. Kieseier, Richard A. Rudick - Neurology 2024 cited by 39

  21. Diet quality is associated with disability and symptom severity in multiple sclerosis

    Authors: Kathryn C. Fitzgerald, Tuula Tyry, Amber Salter, Stacey S. Cofield, Gary Cutter, Robert J. Fox, Ruth Ann Marrie - Neurology 2017 cited by 199

  22. Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial

    Authors: Amit Bar‐Or, Peter A. Calabresi, Douglas L. Arnold, Clyde Markowitz, Stuart Shafer, Lloyd H. Kasper, Emmanuelle Waubant, Suzanne Gazda, Robert J. Fox, Michael Panzara, Neena Sarkar, Sunil Agarwal, Craig H. Smith - Annals of Neurology 2008 cited by 530

  23. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study

    Authors: Bruce D. Trapp, Megan Vignos, Jessica Dudman, Ansi Chang, Elizabeth Fisher, Susan M. Staugaitis, Harsha Battapady, Sverre Mørk, Daniel Ontaneda, Stephen E. Jones, Robert J. Fox, Jacqueline Chen, Kunio Nakamura, Richard A. Rudick - The Lancet Neurology 2018 cited by 145

  24. Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis

    Authors: Jeffrey A. Cohen, Peter B. Imrey, Sarah M. Planchon, Robert Bermel, Elizabeth Fisher, Robert J. Fox, Amit Bar‐Or, Susan L Sharp, Thomai T Skaramagas, Patricia Jagodnik, Matt Karafa, Shannon L. Morrison, Jane Reese Koç, Stanton L. Gerson, Hillard M. Lazarus - Multiple Sclerosis Journal 2017 cited by 119